Business Wire

Biote Formalizes Commitment to Men’s Hormone Health With Launch of New Men’s Health Division

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading provider of hormone optimization, has announced the launch of a new Men’s Health Division with the ...

OBGYN Specialists of Columbus Educates Women on BHRT Basics: Insurance, Costs, and What to Expect with BioTE

COLUMBUS, GA, UNITED STATES, March 3, 2026 /EINPresswire.com/ -- OBGYN Specialists of Columbus is helping women better ...
Nasdaq

Craig-Hallum bullish on Biote, initiates with a Buy

As previously reported, Craig-Hallum initiated coverage of Biote (BTMD) with a Buy rating and $12 price target Consumer interest in next-gen therapies like hormone replacement therapy, or HRT, is ...
Nasdaq

Biote Debuts as Publicly Traded Company Focused on Transforming Hormone Optimization Industry

IRVING, Texas--(BUSINESS WIRE)-- biote Corp., (Nasdaq: BTMD) (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today ...
Business Wire

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

Biote Reports Fourth Quarter and Full Year 2025 Financial Results

Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners’ patients, today announced financial results for the ...